Detail Information of Xenobiotics-driven Alterations in 3D Complexes
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0247 Transporter Info | ||||
Gene Name | SLC29A1 | ||||
Transporter Name | Equilibrative nucleoside transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
Xenobiotic Name | Phlorizin Drug Info | ||||
Xenobiotic Type | Investigative Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 6072 | ||||
Docking Score | -11.241 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C21H24O10 | ||||
Molecular Weight | 436.4 | ||||
Canonical SMILES |
C1=CC(=CC=C1CCC(=O)C2=C(C=C(C=C2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O
|
||||
InChI |
InChI=1S/C21H24O10/c22-9-16-18(27)19(28)20(29)21(31-16)30-15-8-12(24)7-14(26)17(15)13(25)6-3-10-1-4-11(23)5-2-10/h1-2,4-5,7-8,16,18-24,26-29H,3,6,9H2/t16-,18-,19+,20-,21-/m1/s1
|
||||
InChIKey | IOUVKUPGCMBWBT-QNDFHXLGSA-N | ||||
Pharmaceutical Properties | Xlogp | 1.2 | Rotatable Bond Count | 7 | |
Hydrogen Bond Donor Count | 7 | Hydrogen Bond Acceptor Count | 10 | ||
Xenobiotic Name | 6-Benzylthioinosine Drug Info | ||||
Xenobiotic Type | Investigative Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 95263 | ||||
Docking Score | -11.226 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C17H18N4O4S | ||||
Molecular Weight | 374.4 | ||||
Canonical SMILES |
C1=CC=C(C=C1)CSC2=NC=NC3=C2N=CN3C4C(C(C(O4)CO)O)O
|
||||
InChI |
InChI=1S/C17H18N4O4S/c22-6-11-13(23)14(24)17(25-11)21-9-20-12-15(21)18-8-19-16(12)26-7-10-4-2-1-3-5-10/h1-5,8-9,11,13-14,17,22-24H,6-7H2
|
||||
InChIKey | OMJRXFOHHLLDFR-UHFFFAOYSA-N | ||||
Pharmaceutical Properties | Xlogp | 1.6 | Rotatable Bond Count | 5 | |
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 8 | ||
Xenobiotic Name | Sulindac Drug Info | ||||
Xenobiotic Type | Approved Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 1548887 | ||||
Docking Score | -11.134 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C20H17FO3S | ||||
Molecular Weight | 356.4 | ||||
Canonical SMILES |
CC\\1=C(C2=C(/C1=C\\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
|
||||
InChI |
InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-
|
||||
InChIKey | MLKXDPUZXIRXEP-MFOYZWKCSA-N | ||||
Pharmaceutical Properties | Xlogp | 3.4 | Rotatable Bond Count | 4 | |
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 5 | ||
Pagination
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.